Use of a birnavirus alone or in combination therapy for the treatment of cancer
AssigneeProbiogen AG
InventorsTibor Bakacs, Volker Sandig, Shimon Slavin, Sven Krugener, Wolfgang W. Renz, Imre Kovesdi, Alexander Karlas, Deborah Horn
Life of this patent
Estimating the term…
Abstract
The present invention relates to a birnavirus for use in the treatment or prevention of cancer. Further, the present invention relates to a combination comprising at least one birnavirus and at least one further active agent for use in the treatment or prevention of cancer. Furthermore, the present invention relates to a pharmaceutical composition comprising the birnavirus or the combination for use in the treatment or prevention of cancer.
Claims27
A method for treating or preventing cancer comprising the step of:
- administering a birnavirus to a subject in need thereof, thereby treating or preventing cancer in the subject.
5-10. (canceled)
(canceled)
(canceled)
16-17. (canceled)
20-21. (canceled)
A method for treating or preventing cancer comprising the step of:
- administering a combination comprising at least one birnavirus and at least one further active agent suitable for the treatment or prevention of cancer to a subject in need thereof, thereby treating or preventing cancer in the subject.
(canceled)
27-35. (canceled)
A kit comprising
- (i) a packaging material, and
- (ii) a birnavirus or a composition comprising the birnavirus, or an oral or nasal applicator, wherein the applicator comprises (a) a reservoir comprising the birnavirus or the composition, and (b) a mouth piece or nose piece, wherein the mouth piece or the nose piece is connected with/attached to the reservoir.
(canceled)
42-43. (canceled)
Dependencies are inferred from the claim text.